Preclinical Development Handbook: ADME and Biopharmaceutical Properties

Capa
Shayne Cox Gad
John Wiley & Sons, 14 de mar. de 2008 - 1352 páginas
A clear, straightforward resource to guide you through preclinical drug development

Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic, comprehensive reference to prioritizing and optimizing leads, dose formulation, ADME, pharmacokinetics, modeling, and regulations. This authoritative, easy-to-use resource covers all the issues that need to be considered and provides detailed instructions for current methods and techniques.

Each chapter is written by one or more leading experts in the field. These authors, representing the many disciplines involved in preclinical toxicology screening and testing, give you the tools needed to apply an effective multidisciplinary approach. The editor has carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear.

Among the key topics covered are:
*

Modeling and informatics in drug design
*

Bioanalytical chemistry
*

Absorption of drugs after oral administration
*

Transporter interactions in the ADME pathway of drugs
*

Metabolism kinetics
*

Mechanisms and consequences of drug-drug interactions

Each chapter offers a full exploration of problems that may be encountered and their solutions. The authors also set forth the limitations of various methods and techniques used in determining the safety and efficacy of a drug during the preclinical stage.

This publication should be readily accessible to all pharmaceutical scientists involved in preclinical testing, enabling them to perform and document preclinical safety tests to meet all FDA requirements before clinical trials may begin.
 

Conteúdo

Contents
3
Modeling and Informatics in Drug Design 1
16
2
48
4
118
Developments and Validation
151
Chemical and Physical Characterizations of Potential
211
Permeability Assessment
227
How and Where Are Drugs Absorbed?
249
Utilization of In Vitro Cytochrome P450 Inhibition Data
775
In Vivo Metabolism in Preclinical Drug Development
829
Scientific
853
von Moltke Tufts University School of Medicine Boston Massachusetts
879
Jayesh Vora PRTM Management Consultants Mountain View California Data
902
Species Comparison of Metabolism in Microsomes and Hepatocytes
919
Metabolite Profiling and Structural Identification
937
Ruiwen Zhang University of Alabama at Birmingham Birmingham Alabama
975

Absorption of Drugs after Oral Administration
281
Movement of Drugs through the Body
323
The BloodBrain Barrier and Its Effect on Absorption
353
Transporter Interactions in the ADME Pathway of Drugs
407
Accumulation of Drugs in Tissues
429
Salt and Cocrystal Form Selection
455
Dissolution
483
Physical and Chemical
545
Dosage Formulation
571
Cytochrome P450 Enzymes
627
Metabolism Kinetics
697
Drug Clearance
715
In Vitro Metabolism in Preclinical Drug Development
743
Allometric Scaling
1009
Interrelationship between Pharmacokinetics and Metabolism
1037
Experimental Design Considerations in Pharmacokinetic Studies
1059
32
1070
Mass Balance Studies
1103
Pharmacodynamics
1133
Physiologically Based Pharmacokinetic Modeling
1167
Irit Ziv Optimata Ltd RamatGan Israel Mathematical Modeling as a
1229
37
1268
Data Analysis
1309
Index
1323
Direitos autorais

Outras edições - Ver todos

Termos e frases comuns

Sobre o autor (2008)

SHAYNE COX GAD, PHD, DABT, ATS, is the Principal of Gad Consulting Services. Dr. Gad has more than thirty years of experience as a toxicologist, statistical consultant, manager, and general consultant on research and development in the chemical, consumer product, contract testing, biotechnology, medical device, and pharmaceutical industries. He is the author of thirty- four books and numerous papers, presentations, and other publications.

Informações bibliográficas